Why the study?
Females historically have lower rates of cardiovascular testing than males, and it was unknown whether clinical decision pathways using standardized risk stratification could minimize sex-based differences.
Does a clinical decision pathway utilizing the HEART score minimize sex-based differences in the non-invasive workup of chest pain in the emergency department?
Does a clinical decision pathway utilizing the HEART score minimize sex-based differences in the non-invasive workup of chest pain in the emergency department?
A standardized clinical decision pathway for chest pain eliminates sex disparities in non-invasive testing, though high-risk males still undergo more invasive procedures and experience more MACE.
Answers are grounded in this paper and cite their sources.
Supports HEART pathway for equitable non-invasive testing; leaves open explanations for higher angiography, PCI, and MACE in high-risk males.
BACKGROUND: Females have historically lower rates of cardiovascular testing when compared to males. Clinical decision pathways (CDP) that utilize standardized risk-stratification methods may balance this disparity. We sought to determine whether clinical decision pathways could minimize sex-based differences in the non-invasive workup of chest pain in the emergency department (ED). Moreover, we evaluated whether the HEART score would minimize sex-based differences in risk-stratification. METHODS: We conducted a retrospective cohort review of adult ED encounters for chest pain where CDP was employed. Primary outcome was any occurrence of non-invasive imaging (coronary CTA, stress imaging), invasive testing, intervention (PCI or CABG), or death. Secondary outcomes were 30-day major adverse cardiac events (MACE). We stratified HEART scores and primary/secondary outcomes by sex. RESULTS: A total of 1078 charts met criteria for review. Mean age at presentation was 59 years. Females represented 47% of the population. Low, intermediate, and high-risk patients as determined by the HEART score were 17%, 65%, and 18% of the population, respectively, without any significant differences between males and females. Non-invasive testing was similar between males and females when stratified by risk. Males categorized as high risk underwent more coronary angiogram (33% vs. 16%, p = 0.01) and PCI (18% vs. 8%, p = 0.04) than high risk females, but this was not seen in patients categorized as low or intermediate risk. Males experienced more MACE than females (8% vs. 3%, p = 0.001). CONCLUSIONS: We identified no sex-based differences in risk-stratification or non-invasive testing when the CDP was used. High risk males, however, underwent more coronary angiogram and PCI than high risk females, and consequently males experienced more overall MACE than females. This disparity may be explained by sex-based differences in the pathophysiology driving each patient's presentation.
No takes yet. Share an insight, caveat, or question.
Titus et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: